4.8 Review

The bright side of dark matter: lncRNAs in cancer

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 126, Issue 8, Pages 2775-2782

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI84421

Keywords

-

Funding

  1. RSNA (Research Resident Grant) [RR1420]
  2. Prostate Cancer Foundation

Ask authors/readers for more resources

The traditional view of genome organization has been upended in the last decade with the discovery of vast amounts of non-protein-coding transcription. After initial concerns that this dark matter of the genome was transcriptional noise, it is apparent that a subset of these noncoding RNAs are functional. Long noncoding RNA (lncRNA) genes resemble protein-coding genes in several key aspects, and they have myriad molecular functions across many cellular pathways and processes, including oncogenic signaling. The number of lncRNA genes has recently been greatly expanded by our group to triple the number of protein-coding genes; therefore, lncRNAs are likely to play a role in many biological processes. Based on their large number and expression specificity in a variety of cancers, lncRNAs are likely to serve as the basis for many clinical applications in oncology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available